Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry

BackgroundChronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent inflammatory condition often associated with type 2 inflammation. While biologics are a promising treatment for patients with uncontrolled CRSwNP, real-world evidence is needed to optimize their use. The InternatioNal seVerE...

Full description

Bibliographic Details

Published in:	Frontiers in Allergy
Main Authors:	Vibeke Backer, Eugenio De Corso, Geoffrey Mortuaire, Emmanuel Prokopakis, Anette Drøhse Kjeldsen, Philippe Gevaert, Adam M. Chaker, Luisa Azevedo, Christian von Buchwald, Emilie Bequignon, Eliza Brozek-Madry, Jannis Constantinidis, Marjolein Cornet, Wytske J. Fokkens, Peter G. Gibson, Aleksander Grande Hansen, Joaquim Mullol, Sietze Reitsma, Sanna Toppila-Salmi, Michael B. Soyka, Martin Wagenmann, Peter W. Hellings
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	chronic rhinosinusitis with nasal polyp CRSwNP type-2 inflammation comorbididites monoclonal antibodies systematic assessment
Online Access:	https://www.frontiersin.org/articles/10.3389/falgy.2025.1680703/full